Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease

Reliable non-invasive biomarkers for the surveillance of patients at risk of hepatocellular carcinoma (HCC) development represent an unmet medical need. Recently, the liver-cancer-specific isoform of serine protease inhibitor Kazal (LC-SPIK) has been proposed as a valuable biomarker for the detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Caviglia, Gian Paolo, Nicolosi, Aurora, Abate, Maria Lorena, Carucci, Patrizia, Rosso, Chiara, Rolle, Emanuela, Armandi, Angelo, Aneli, Serena, Olivero, Antonella, Risso, Alessandra, Ribaldone, Davide Giuseppe, Fermer, Christian, Saracco, Giorgio Maria, Gaia, Silvia, Bugianesi, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406939/
https://www.ncbi.nlm.nih.gov/pubmed/36005169
http://dx.doi.org/10.3390/curroncol29080431

Ejemplares similares

Ejemplares similares